Tag: UT Health San Antonio

Vitanova Biomedical Develops Light-Activated Cancer Therapy Pioneered by UTSA Researcher
Articles, Featured

Vitanova Biomedical Develops Light-Activated Cancer Therapy Pioneered by UTSA Researcher

The San Antonio-based biotech startup Vitanova Biomedical is developing a new way to treat cancer called photodynamic therapy that causes no side effects and can kill many types of cancers. The preclinical stage biotech company is commercializing a novel technique that uses a specific wavelength of light combined with a chemical. The new cancer treatment approach is based on research first done at The University of Texas at San Antonio (UTSA) by Matthew Gdovin when he was an associate professor in UTSA’s biology department. Gdovin pioneered using the photosensitizing agent o-nitrobenzaldehyde (o-NBA) in combination with a specific wavelength of light that activates the drug. This photodynamic therapy triggers the cancer cell to become too acidic and die, a process known as apoptosis....
New Venture Mentoring Service Connects UTSA, UT Health SA Entrepreneurs to Commercialization Expertise
Articles, Featured

New Venture Mentoring Service Connects UTSA, UT Health SA Entrepreneurs to Commercialization Expertise

The University of Texas at San Antonio (UTSA) and UT Health San Antonio (UT Health SA) have joined forces to launch the Venture Mentoring Service San Antonio (VMS-SA), a program that matches experienced mentors with aspiring entrepreneurs. The San Antonio chapter of the Venture Mentoring Service is a sister program of the Massachusetts Institute of Technology Venture Mentoring Service (MITVMS), which launched in 2000. The VMS-SA network is available for startups spinning out from either UTSA or UT Health SA. UTSA's Office of Commercialization and Innovation and UT Health SA's Office of Technology Commercialization will manage the new joint program. VMS-SA is open to all disciplines, with a focus on the biosciences. While in its initial launch phase, the program will focus on compan...
Olifant Medical Device Protecting Healthcare Providers from COVID-19 Wins $1M Air Force Contract
Articles, Featured

Olifant Medical Device Protecting Healthcare Providers from COVID-19 Wins $1M Air Force Contract

As more healthcare providers are exposed to COVID-19 while treating patients, innovators like Dr. Steven Venticinque are developing critically needed solutions. His startup company Olifant Medical won a $1 million Air Force award in mid-July to adapt a protective barrier device that can protect healthcare providers from COVID-19 exposure during medical procedures. This device is not the first invention that has garnered Air Force funding for Venticinque, a UT Health San Antonio anesthesiologist and former Air Force physician. He co-founded Olifant (one of the San Antonio startups to watch in 2019) in 2018 with engineer Justin Rice and scientist Christopher Carroll to bring an improved airway device to market. Carroll is Olifant's chief executive officer, Venticinque is the chief...
Enventure San Antonio To Connect Bioscience Students to Entrepreneurial Opportunities
Articles, Featured

Enventure San Antonio To Connect Bioscience Students to Entrepreneurial Opportunities

Bioscience graduate students face daunting odds at landing a tenure-track faculty position in academia.  In popular fields like biomedicine, fewer than one in six has a chance at a faculty job researching at a university. What options does an early-career bioscience professional have? A new nonprofit organization, launched by biomedical students facing these challenges themselves, want to help enterprising scientists find career options so they can pursue medical innovation in San Antonio’s private sector. Enventure San Antonio (Enventure SA) is a biomedical entrepreneurial community designed to help students and young professionals become leaders in the biomedical and health technology space. Students and young professionals often lack the education and experience to commercia...
UT Health San Antonio TechNovum Accelerator for Researchers Graduates 8 New Companies
Articles, Featured

UT Health San Antonio TechNovum Accelerator for Researchers Graduates 8 New Companies

A new accelerator program designed for aspiring life science entrepreneurs has helped in the formation of eight new biomedical startups. Earlier this year, UT Health San Antonio launched TechNovum, a new technology commercialization accelerator for faculty researchers interested in developing their inventions for the market. John Fritz and Sean Thompson of the Office of Technology Commercialization at UT Health are co-directors and mentors for the new program. The first cohort graduated two therapeutics companies, spurred the development of four new medical devices, and included two digital health startups. The companies are: Atomic Therapeutics, developing novel anticancer therapeutics for leukemia Protectum Oncology, introducing low-dose arsenic for reducing cancer therapy ...
UT Health San Antonio Launches New Accelerator for Researchers
Articles, Featured

UT Health San Antonio Launches New Accelerator for Researchers

A new accelerator program designed for aspiring life science entrepreneurs has joined San Antonio's entrepreneurial ecosystem. Biomedical research institution UT Health San Antonio is launching TechNovum, a new technology commercialization accelerator for faculty researchers interested in developing their inventions for the market. John Fritz and Sean Thompson of the Office of Technology Commercialization at UT Health are co-directors and mentors for the new program and will lead the educational coaching sessions. Each cohort will run annually from June through October. Plans for the first cohort are to invite five to eight teams of founder-inventors to join the program to develop medical devices for the market. The teams will meet weekly, typically in the evening, for two- to three-ho...
BioAffinity Lung Cancer Diagnostic Test Gets Closer to Market with Canadian Patent
Articles, Featured

BioAffinity Lung Cancer Diagnostic Test Gets Closer to Market with Canadian Patent

The San Antonio-based privately held biotech company bioAffinity Technologies announced Monday the Canadian Intellectual Property Office had awarded a patent for its proprietary CyPath© technology used in the early detection of cancer. The patent, titled “System and Method for Analyzing Samples Labeled with 5, 10, 15, 20 Tetrakis (4-Carboxyphenyl) Porphine (TCPP),” is bioAffinity’s third Canadian patent. bioAffinity’s intellectual property (IP) portfolio now consists of 51 awarded patents in 21 countries, with three additional patent applications filed in the U.S. The test is bioAffinity’s solution for the unusually high rate of false positives from computed tomography or CT scans used in early testing of suspected lung cancer. CyPath® Lung’s test uses flow cytometry and proprietary ...
UT Health SA Clinician-Entrepreneur Invents Next-Generation Airway Device
Articles, Featured

UT Health SA Clinician-Entrepreneur Invents Next-Generation Airway Device

However easy it might look in movies or television shows, intubating or inserting a breathing tube into an unconscious person can be quite difficult, especially under stressful emergency conditions. When a patient is not breathing, every second counts until that person can receive oxygen again. San Antonio-based anesthesiologist and critical care physician Steven Venticinque, M.D., knows well the challenges in intubating patients both in the operating room and beyond. During his career in the U.S. Air Force, Venticinque led critical care air transport teams flying in Iraq and Afghanistan. Venticinque has been at UT Health San Antonio since 2007 and is a professor and interim chair of the anesthesiology department at the Joe R. and Teresa Lozano Long School of Medicine. He now car...
GaitIQ Spots Early Signs of Alzheimer’s in Your Walk
Articles, Featured

GaitIQ Spots Early Signs of Alzheimer’s in Your Walk

Can technology help predict your risk for Alzheimer’s disease years or decades before symptoms of dementia appear? One San Antonio team is working to do just that using deep learning and artificial intelligence (AI) to analyze a video taken in your doctor’s office. Rick Morris is the San Antonio-based entrepreneur who founded GaitIQ, an early-stage digital health Software as a Service (SaaS) company in 2017. The GaitIQ cloud-based platform will give healthcare providers an affordable, easy-to-use application to measure a patient’s gait. The technology leverages machine vision, AI, and big data analytics to evaluate subtle changes in the way a person walks that have been linked to the risk for dementia. Changes in gait are important early warning sign of cognitive decline and emerge a...
San Antonio’s Healthcare and Bioscience Industry Tops $40 Billion in Economic Impact for 2017
Articles, Featured

San Antonio’s Healthcare and Bioscience Industry Tops $40 Billion in Economic Impact for 2017

The San Antonio Chamber of Commerce 2018 Healthcare and Bioscience Economic Impact Study is based on 2017 data, according to the study authors economist Richard Butler, Ph.D., and health care administration professor Mary E. Stefl, Ph.D., both from Trinity University. The study completed in 2018 stated its conservative estimate of over $30 billion in impact on San Antonio's economy in 2017. The authors included a more comprehensive analysis of economic impact with data from UT Health San Antonio, Baylor College of Medicine at the Children's Hospital of San Antonio, and some military medical presence in San Antonio. The overall impact rises to more than $40 billion when the comprehensive data is taken into account. This sector employs over 18 percent of San Antonio's population, with...